Dell Technologies vs Insilico Medicine
Relationship
Dell AI Factory with NVIDIA and Biology42: Generative Biologics do comparable work on model training; both also serve buyers who need to train or fine-tune a model; smaller scale (public).
Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.
3 of 7 capabilities — Shares data analysis, knowledge retrieval and model training.
Ludbee capability tags · from the product recordsShared product type — Both ship hardware.
Ludbee product recordsSmaller scale — Insilico Medicine: $4.3B market cap, against Dell Technologies's $360.7B market cap.
Ludbee scale figures · valuation, market cap or revenue estimateAligned comparison
Capability overlap
Shared · 3
Not verified for Insilico Medicine · 4
Recorded for Dell Technologies. Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.
Not verified for Dell Technologies · 5
Recorded for Insilico Medicine. Dell Technologies’s product records say nothing either way — a missing record is not a missing capability.
Products, side by side
Algorithmic pairing — assembled from recorded fields, not hand-checked
Dell Technologies
Hardware
Air-cooled 4U rack server supporting up to eight double-wide PCIe GPUs for flexible AI inference and fine-tuning workloads.
Liquid-cooled 4U rack server with eight NVLink-interconnected NVIDIA HGX B200 GPUs, built for AI inference and model fine-tuning.
Rack-scale server sled pairing NVIDIA Blackwell Ultra GPUs with Grace CPUs over a coherent NVLink memory fabric for large-scale AI training.
Compact workstations built on NVIDIA Grace Blackwell superchips with large unified memory, sold for local large-language-model development and inference.
Insilico Medicine
Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
No counterpart
Dell Technologies sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.
Developer tool
Curated catalogue of AI models and applications preconfigured with optimised containers for one-click on-premises deployment on Dell hardware, built with Hugging Face.
Infrastructure service
Packaged servers, storage, networking and services sold as one route from AI pilot to production, jointly branded with NVIDIA.
Data service
Modular data-readiness offering combining Dell storage engines with analytics, processing, orchestration and search engines to prepare enterprise data for AI training and inference.
Insilico Medicine sells these in a stack layer with no product recorded for Dell Technologies yet — nothing on the other side to compare them against.
Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.